Target intelligence / Profile preview

Non-specific serum protein

Molecular classification
Other, Protein group, Carrier proteins
01

Overview

Non-specific serum protein refers to the heterogeneous group of proteins present in the blood plasma, including albumin, globulins, and fibrinogen. These proteins serve vital physiological roles such as maintaining oncotic pressure, buffering pH, and transporting endogenous substances like hormones, fatty acids, and bilirubin (StatPearls, 2023). In pharmacology, they are not typically viewed as primary therapeutic targets but are crucial determinants of drug pharmacokinetics; the extent of drug binding to these proteins dictates the concentration of free, pharmacologically active drug in the systemic circulation (PubMed, 2021). Clinical conditions that alter protein levels, such as cirrhosis or nephrotic syndrome, can significantly impact the safety and efficacy of highly protein-bound medications. Furthermore, competitive displacement between two drugs for the same binding sites on these proteins can lead to adverse drug-drug interactions (NCBI, 2022). Albumin is the primary binder for acidic drugs, while alpha-1-acid glycoprotein typically binds basic drugs, and understanding these interactions is essential for dose adjustment in specific patient populations.

Other names
Plasma proteinsSerum proteinsBlood proteinsCirculating proteinsTotal serum protein
02

Mechanism of action

Reversible non-specific binding to plasma proteins, primarily albumin and alpha-1-acid glycoprotein, which modulates the free fraction of drugs available for pharmacological action.

03

Biological functions

Transport of endogenous and exogenous substancesMaintenance of oncotic pressurepH bufferingImmune responseBlood coagulation
04

Disease associations

InflammationLiver cirrhosisNephrotic syndromeMalnutritionAcute phase response
05

Safety considerations

Drug-drug interactions via protein displacementToxicity due to increased free drug fraction in hypoalbuminemiaAltered pharmacokinetics in patients with hepatic or renal dysfunction
06

Interacting drugs

Warfarin

5 more in the full profile.

07

Biomarkers

Serum albumin concentrationTotal serum proteinAlpha-1-acid glycoprotein (AAG) levelsAlbumin-to-globulin (A/G) ratio

Beyond the preview

Go deeper on Non-specific serum protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-specific serum protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call